Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Portola Pharma drug reverses effect of anti-clotting drugs in study
Yahoo/Reuters
Wednesday, October 1, 2014 - 9:22am
tags:
Portola Pharmaceuticals, andexanet alfa
Novartis drops out of hep C race, punting a $440M Enanta pact
Fierce Biotech
Wednesday, October 1, 2014 - 9:19am
tags:
Novartis, hepatitis C, Enanta Pharmaceuticals, EDP-239, alisporivir
Tekmira may launch clinical trial of Ebola drug later this year: RBC
Marketwatch
Wednesday, October 1, 2014 - 8:35am
tags:
Tekmira, ebola virus, clinical trials, TKM-EBOLA
Endo Said to Pay $400 Million Plus in Vaginal-Mesh Accord
Bloomberg
Wednesday, October 1, 2014 - 8:26am
tags:
Endo Health Solutions, pelvic mesh
FierceMedicalDevices' 2014 Fierce 15
Fierce Medical Devices
Wednesday, October 1, 2014 - 8:20am
tags:
devices
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Reuters
Wednesday, October 1, 2014 - 8:19am
tags:
Ardelyx, IBS, irritable bowel syndrome, tenapanor, AstraZeneca Pharma India
Sunshine fact: $3.5B + 546,000 docs equals one unwieldy database
Fierce Pharma Marketing
Wednesday, October 1, 2014 - 8:12am
tags:
Physician Payment Sunshine Act
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Bidness Etc.
Wednesday, October 1, 2014 - 8:09am
tags:
tax inversions, intellectual property, Gilead Sciences, Alexion
Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada
Yahoo
Wednesday, October 1, 2014 - 8:07am
tags:
Sanofi Pasteur, flu vaccines, Canada, Fluzone Quadrivalent
Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx
Yahoo
Wednesday, October 1, 2014 - 8:05am
tags:
GSK, Isis Pharmaceuticals, ISIS-GSK4Rx, Ocular Disease
Melanoma Treatment Battle Between Roche And GSK Heats Up
Bidness Etc.
Tuesday, September 30, 2014 - 6:27pm
tags:
melanoma, Roche, GSK, Zelboraf, Tafinlar
Novartis ordered to face U.S. lawsuit over doctor kickbacks
Reuters
Tuesday, September 30, 2014 - 6:21pm
tags:
Novartis, kickbacks, whistleblower lawsuits
Ebola Drugmaker Shares Surge After CDC Confirms First US Case
Yahoo/Business Insider
Tuesday, September 30, 2014 - 6:18pm
tags:
ebola virus, CDC, Tekmira Pharmaceuticals, Biocryst
Doctors Pull In $3.5 Billion in 5 Months From Drug and Device Companies
Yahoo/Bloomberg
Tuesday, September 30, 2014 - 6:16pm
tags:
physicial payments, Physician Payment Sunshine Act
Should Endocyte abandon a cancer drug that works?
Indianapolis Business Journal, IN
Tuesday, September 30, 2014 - 12:44pm
tags:
Endocyte, vintafolide, lung cancer
FDA says no to anti-addiction rule on Ritalin, painkillers
In-Pharma Technologist
Tuesday, September 30, 2014 - 12:41pm
tags:
FDA, Ritalin, painkillers
Could Pay-For-Performance Lead To Overuse Of Antibiotics?
Forbes
Tuesday, September 30, 2014 - 12:40pm
tags:
antibiotics
The FDA's less-stringent 510(k) clearance process comes under fire (again) in a pair of new studies.
Mass Device
Tuesday, September 30, 2014 - 12:08pm
tags:
FDA, devices
Valeant has a Wrinkle: FDA Letter Cites Problems With a Facial Filler
WSJ Pharmalot
Tuesday, September 30, 2014 - 11:46am
tags:
Valeant Pharmaceuticals, Allergan, FDA, facial fillers, Sculptra
Valeant's Bausch + Lomb Announces Results on Lotemax
Yahoo/Zacks.com
Tuesday, September 30, 2014 - 11:41am
tags:
Valeant Pharmaceuticals, Bausch & Lomb, Lotemax, cataract surgery

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.